Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Recruiting 6Active not recruiting 5Completed 3Not yet recruiting 1

Sponsor Class

NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Wilms Tumor 3Beckwith-Wiedemann Syndrome 1

Interventions

pembrolizumab 244Nivolumab 140Cisplatin 135Cyclophosphamide 134Paclitaxel 113Carboplatin 108Gemcitabine 98Radiotherapy 83Dexamethasone 83Docetaxel 77atezolizumab 68Ipilimumab 68Doxorubicin 62Fluorouracil 60Blood Specimen Collection 58Bevacizumab 58fludarabine 54Rituximab 54Etoposide 53Oxaliplatin 52Surveys and Questionnaires 49Lenalidomide 49Prednisone 47Standard of Care 45Magnetic Resonance Spectroscopy 45Cetuximab 44Capecitabine 44lenvatinib 43Radiosurgery 43durvalumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Dactinomycin × 1 year × Clear all
NCT00352534 2026-06-03

Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor

Children's Oncology Group

Phase 3 Completed
808 enrolled 11 charts
Genitourinary

Wilms Tumor

NCT00379340 2026-06-03

Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

Children's Oncology Group

Phase 3 Completed
395 enrolled 15 charts
Genitourinary

Wilms Tumor

NCT00945009 2026-06-03

Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor

Children's Oncology Group

Phase 3 Completed
249 enrolled 14 charts
Genitourinary

Beckwith-Wiedemann Syndrome, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡